Brief: Vor Biopharma Inc - On June 4, 2024, Nathan Jorgensen Notified Co Of His Resignation As Chief Financial Officer Of Company, Effective As Of June 21
10/06/2024 21:56
Vor Biopharma Inc VOR.O :
* VOR BIOPHARMA INC - ON JUNE 4, 2024, NATHAN JORGENSEN
NOTIFIED
CO OF HIS RESIGNATION AS CHIEF FINANCIAL OFFICER OF COMPANY,
EFFECTIVE AS OF JUNE 21
* VOR BIOPHARMA INC - BOARD DESIGNATED ROBERT ANG AS
COMPANY'S
INTERIM PRINCIPAL FINANCIAL OFFICER
Source text for Eikon: ID:n0001193125-24-158320
Further company coverage: VOR.O
Recent news on Vor Biopharma
See all newsBrief: Telitacicept Demonstrates Durable Preservation Of Kidney Function Through Two Years In Phase 3 Teligan Trial In Iga Nephropathy
Vor Bio says its experimental drug slowed loss of kidney function in late-stage study
U.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
U.S. STOCKS ON THE MOVE-Snowflake, Cboe, Oracle
US STOCKS ON THE MOVE-Veracyte, Staar Surgical, Corning